当前位置:首页 - 行情中心 - 海尔生物(688139) - 财务分析

海尔生物

(688139)

  

流通市值:110.33亿  总市值:110.33亿
流通股本:3.18亿   总股本:3.18亿

海尔生物(688139)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2023年年度实现净利润4.12亿元,每股收益1.28元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2023年年度最新股东权益443996.30万元,未分配利润185611.84万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2023年年度最新总资产552568.26万元,负债108571.96万元。

利润表
报告期2023-12-312023-09-302023-06-302023-03-31
营业总收入2,280,896,019.231,826,339,651.431,270,455,870.9686,668,622.18
营业总成本1,966,937,346.461,528,552,037.641,034,950,299.72557,268,271.77
营业利润438,401,339.39395,179,711.38312,024,833.1151,342,584.47
利润总额434,491,209.43391,622,464.17307,265,104.31151,993,528.18
净利润412,058,658.76365,645,845.17284,211,629.04139,509,813.51
其他综合收益-43,521,492.11-30,515,814.23-29,978,428.7398,055.44
综合收益总额368,537,166.65335,130,030.94254,233,200.31139,607,868.95
资产负债表
报告期2023-12-312023-09-302023-06-302023-03-31
流动资产合计2,536,028,043.522,636,531,294.082,893,908,129.693,224,795,967.12
非流动资产合计2,989,654,525.152,855,835,677.942,595,513,915.322,301,977,619.64
资产总计5,525,682,568.675,492,366,972.025,489,422,045.015,526,773,586.76
流动负债合计941,663,492.8916,478,213.35993,177,820.341,086,340,517.7
非流动负债合计144,056,077.15158,545,718.83160,373,499.2154,431,804.37
负债合计1,085,719,569.951,075,023,932.181,153,551,319.541,240,772,322.07
归属于母公司股东权益合计4,230,710,929.54,207,513,559.884,128,038,704.494,157,390,941.28
股东权益合计4,439,962,998.724,417,343,039.844,335,870,725.474,286,001,264.69
负债和股东权益合计5,525,682,568.675,492,366,972.025,489,422,045.015,526,773,586.76
现金流量表
报告期2023-12-312023-09-302023-06-302023-03-31
经营活动现金流入小计2,434,712,610.551,815,303,786.831,230,823,379.21643,402,402.79
经营活动现金流出小计2,185,448,075.961,647,807,501.61,117,243,217.79537,150,622.24
经营活动产生的现金流量净额249,264,534.59167,496,285.23113,580,161.42106,251,780.55
投资活动现金流入小计5,579,852,006.134,714,330,619.043,217,731,811.241,793,270,295.01
投资活动现金流出小计5,327,095,930.884,361,360,720.013,162,387,397.11,549,642,604.71
投资活动产生的现金流量净额252,756,075.25352,969,899.0355,344,414.14243,627,690.3
筹资活动现金流入小计11,895,0008,395,0006,395,0001,275,000
筹资活动现金流出小计180,194,490.64177,498,644.4171,273,569.737,186,212.16
筹资活动产生的现金流量净额-168,299,490.64-169,103,644.4-164,878,569.73-5,911,212.16
汇率变动对现金及现金等价物的影响-8,238,268.42-6,078,181.47-2,297,481.26-14,527,686.97
现金及现金等价物净增加额325,482,850.78345,284,358.391,748,524.57329,440,571.72
期末现金及现金等价物余额1,256,646,564.21,276,448,071.81932,912,237.991,260,604,285.14
最新报告期:2024-04-11
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
兴业证券东楠,孙媛媛,黄翰漾1.642.092.622024-04-11
浙商证券孙建1.742.102.622024-04-06
华创证券郑辰,李婵娟1.561.932.352024-04-01
中国银河程培1.591.972.412024-03-29
东吴证券朱国广1.581.972.392024-03-29
TOP↑